Oman Medical Speciality Board

Quick facts

Marketed products

• nebulized epinephrine · Pulmonology / Emergency Medicine
  Nebulized epinephrine is an inhaled alpha and beta-adrenergic agonist that rapidly constricts airway blood vessels and relaxes bronchial smooth muscle to reduce airway edema and improve airflow.

Phase 3 pipeline

• Intravenous Diltiazem · Cardiovascular
  Diltiazem is a non-dihydropyridine calcium channel blocker that inhibits calcium influx into cardiac and vascular smooth muscle cells, reducing heart rate and blood pressure.
• Placabo · Other

Phase 2 pipeline

• Intravenous Ketorolac Tromethamine · Pain Management
  Intravenous Ketorolac Tromethamine is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting the enzyme cyclooxygenase (COX), which is involved in the production of prostaglandins, leading to reduced inflammation and pain.

Phase 1 pipeline

• Lidocaine, a local anaesthetic.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Oman Medical Speciality Board portfolio CI brief
• Oman Medical Speciality Board pipeline updates RSS